Want to donate to Global Vaccines? Click here

Global Vaccines, Inc.

A not-for-profit company, whose mission is to develop vaccines against disease targets most prevalent in undeveloped and underdeveloped countries

The mission of Global Vaccines (GVI) is to apply state-of-the-art vaccine technologies and innovative business strategies to the design and development of affordable vaccines for diseases of resource poor nations. We intend to accomplish this goal through an unique combination of philanthropy, government research grant funding and market incentives. The need is urgent: 2/3 of the human population makes less than $2 per day, while many new vaccines cost up to $360 per vaccination. Critical vaccines for HIV, malaria, dengue fever, and tuberculosis do not exist at any price.

Global Vaccines is a not-for-profit company that acquires state-of-the-art vaccine technologies and applies them to diseases of poorer countries. We develop platform vaccine technologies that can be applied to a broad spectrum of disease targets of both developed and undeveloped countries. Global will apply these technologies to diseases of undeveloped countries and also may sublicense these technologies to commercial companies for use in the more profitable markets of developed countries. By sublicensing these value added technologies to the commercial pharmaceutical industry, Global Vaccines provides new technologies to the commercial market that are more fully proven and therefore less financially risky.

“Despite recent progress in controlling malaria worldwide, the disease continues to kill more than 700,000 people, primarily young children, every year,”

  —Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases